NILOTINIB D-TARTRATE

Clinical safety rating: avoid

Strong CYP3A4 inhibitors may increase levels and inducers may decrease levels Can cause QT prolongation and sudden death.

How it works

Mechanism information is still being processed. Check the DailyMed link in the sidebar for the official prescribing information.

Capsule 200 mg - Oral

Dosage form	CAPSULE
Renal impairment	Consult protocols for adjustment.
Liver impairment	Consult protocols for adjustment.

Clinical note

Strong CYP3A4 inhibitors may increase levels and inducers may decrease levels Can cause QT prolongation and sudden death.

FDA category

Category Contraindicated

QT prolongation

Loading safety data…

Clinical safety rating: avoid

Strong CYP3A4 inhibitors may increase levels and inducers may decrease levels Can cause QT prolongation and sudden death.

Mechanism information is still being processed. Check the DailyMed link in the sidebar for the official prescribing information.

Capsule 200 mg - Oral

Dosage form	CAPSULE
Renal impairment	Consult protocols for adjustment.
Liver impairment	Consult protocols for adjustment.

Clinical note

Strong CYP3A4 inhibitors may increase levels and inducers may decrease levels Can cause QT prolongation and sudden death.

FDA category

Category Contraindicated

QT prolongation

Loading safety data…